Aimed Alliance Releases New Explainer on 340B Program
On October 22, Aimed Alliance published a new resource on the 340B Drug Pricing Program (340B Program). The 340B program…
Browsing: Drug Pricing: Resources
Colorado Sets Nation’s First UPL, Raising Patient Safeguards Concerns
On October 3, the Colorado Prescription Drug Affordability Board (PDAB) voted to establish an upper payment limit (UPL) for Enbrel,…
Aimed Alliance Calls on FDA to Clarify Mandated Use of Drug Importation Programs
On October 7, 2025, Aimed Alliance sent a follow-up letter to the U.S. Food and Drug Administration (FDA) regarding the…
Aimed Alliance Shares Concerns Regarding Affordability Review Process with Oregon PDAB
Aimed Alliance submitted a comment to the Oregon Prescription Drug Affordability Board (PDAB) urging it to maintain a careful, evidence-based…
Aimed Alliance Urges MD PDAB to Conduct Patient-Centered, Evidence-Based Reviews
Prior to the Maryland Prescription Drug Affordability Board’s July meeting to conduct cost affordability reviews for Farxiga and Jardiance, Aimed…
Aimed Alliance Urges CMS to Prioritize Transparency in IRA Negotiations
On June 26, 2025, Aimed Alliance submitted a comment to the Centers for Medicare & Medicaid Services (CMS) on its…
New Analysis Warns IRA Changes Could Raise Drug Costs for Most Medicare Beneficiaries
The Inflation Reduction Act (IRA) aimed to lower prescription drug costs by capping annual out-of-pocket spending for Medicare beneficiaries at…
Aimed Alliance Opposes Nevada’s MFP Bill
Aimed Alliance sent a letter to Governor Lombardo opposing Nevada Assembly Bill 259, which would cap health plan reimbursement for…
IRA Price Controls May Be Linked to Higher Out-of-Pocket Drug Costs
A new analysis from the Pioneer Institute shows that federal price controls under the Inflation Reduction Act (IRA) may be…
Oregon Senator Delays Bill Granting PDAB UPL Authority Amid Uncertainty
Oregon Senator Deb Patterson, Chair of the Senate Health Care Committee, has decided not to introduce a bill this session…